Business Wire07.24.18
LivaNova PLC said its Board of Directors has added William A. Kozy, retired executive vice president and chief operating officer at Becton, Dickinson and Company (BD), to its ranks during its recent annual general meeting.
“Bill brings extensive board and healthcare experience to LivaNova from his career of more than 40 years in the global medical technology industry. He is a revered business leader and a valuable addition to our board,” Board Chairman Daniel J. Moore said. “Bill has a wealth of management experience and broad knowledge of global strategy, manufacturing, M&A and product development—all relevant to our business.”
Kozy joined BD in 1974 and was ultimately responsible for all worldwide businesses of the company, with a specific focus on profitable revenue growth and talent development. He held several senior executive positions within the company, including president of BD Diagnostics from 2003 to 2006.
“Bill joins LivaNova at an exciting time,” said Damien McDonald, LivaNova CEO. “His insight, judgment and global perspective will add value to the board as we continue to transform our business. We look forward to his contributions.”
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s technologies and breakthrough treatments provide solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London, LivaNova has a presence in more than 100 countries worldwide. The company currently employs more than 3,500 employees. LivaNova operates as two businesses: Cardiac Surgery and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston, respectively.
“Bill brings extensive board and healthcare experience to LivaNova from his career of more than 40 years in the global medical technology industry. He is a revered business leader and a valuable addition to our board,” Board Chairman Daniel J. Moore said. “Bill has a wealth of management experience and broad knowledge of global strategy, manufacturing, M&A and product development—all relevant to our business.”
Kozy joined BD in 1974 and was ultimately responsible for all worldwide businesses of the company, with a specific focus on profitable revenue growth and talent development. He held several senior executive positions within the company, including president of BD Diagnostics from 2003 to 2006.
“Bill joins LivaNova at an exciting time,” said Damien McDonald, LivaNova CEO. “His insight, judgment and global perspective will add value to the board as we continue to transform our business. We look forward to his contributions.”
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s technologies and breakthrough treatments provide solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London, LivaNova has a presence in more than 100 countries worldwide. The company currently employs more than 3,500 employees. LivaNova operates as two businesses: Cardiac Surgery and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston, respectively.
